Systemic Mast Cell Disease Without Associated Hematologic Disorder: A Combined Retrospective and Prospective Study
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (11) , 1169-1175
- https://doi.org/10.4065/77.11.1169
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Demonstration That Human Mast Cells Arise From a Progenitor Cell Population That Is CD34+, c-kit+, and Expresses Aminopeptidase N (CD13)Blood, 1999
- Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell populationBlood, 1994
- Systemic MastocytosisNew England Journal of Medicine, 1992
- Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosisThe American Journal of Medicine, 1991
- Systemic Mastocytosis: Retrospective Review of a Decade's Clinical Experience at the Brigham and Women's HospitalJournal of Investigative Dermatology, 1991
- Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disordersBritish Journal of Haematology, 1990
- Systemic Mast Cell DiseaseMedicine, 1988
- Significance of systemic mast cell disease with associated hematologic disordersCancer, 1988
- Tissue mast cells in health and diseasePathology - Research and Practice, 1985
- Mast cells and mast cell neoplasia: a review*Histopathology, 1979